These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1203089)

  • 1. Immunological investigation and immunotherapy approaches in cancer patients.
    Luporini G; Clerici M; Montinari F; Fraschini P; Besana C
    Boll Ist Sieroter Milan; 1975 Oct; 54(4):331-6. PubMed ID: 1203089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD; Lamm DL
    Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the restoration effect of Pseudomonas aeruginosa, BCG and poly I: poly C on cancer patients non responsive to recall antigen delayed hypersensitivity.
    Mathé G; De Vassal F; Gouveia J; Simmler MC; Misset JL
    Biomedicine; 1977 Dec; 27(9-10):328-30. PubMed ID: 414799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological status and surgery of cancer of the lung. Prognostic aspects and therapeutic prospects].
    Fegiz G; Di Paola M; Colizza S
    Minerva Chir; 1977 Jun; 32(11):677-82. PubMed ID: 329159
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy: concepts and nursing implications.
    McCalla JL
    Nurs Clin North Am; 1976 Mar; 11(1):59-71. PubMed ID: 1083016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy.
    Little AG; DeMeester TR; Ferguson MK; Skinner DB; Hoffman PC; Skosey C; Blough RR; Golomb HM
    Surgery; 1986 Oct; 100(4):621-8. PubMed ID: 3020725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer.
    Webster DJ; Chare MJ; Baum M
    Dev Biol Stand; 1977 Apr 13-15; 38():467-70. PubMed ID: 608540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local BCG-immunotherapy in bladder cancer patients. Immunological follow-up studies.
    Seyfarth M; Hudemann B; Nizze H; Riedel H; Werner H
    Arch Geschwulstforsch; 1982; 52(1):63-6. PubMed ID: 7082133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Critical study of immunological assessment in cancer patients (author's transl)].
    Bagarry-Liegey D; Meyer G
    Bull Cancer; 1981; 68(5):403-16. PubMed ID: 7332788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
    Stojadinovic A; Mittendorf EA; Holmes JP; Amin A; Hueman MT; Ponniah S; Peoples GE
    Ann Surg Oncol; 2007 Dec; 14(12):3359-68. PubMed ID: 17906897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active specific immunotherapy with an autologous tumor cell vaccine in patients with resected non-small cell lung cancer.
    Schulof RS; Mai D; Nelson MA; Paxton HM; Cox JW; Turner ML; Mills M; Hix WR; Nochomovitz LE; Peters LC
    Mol Biother; 1988; 1(1):30-6. PubMed ID: 2855788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
    Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
    Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intralymphatic B.C.G. infusions. Preliminary results (40 cases)].
    Abbes M; Ayraud N; Schneider M; Cambon P
    Nouv Presse Med; 1976 Oct; 5(35):2303-6. PubMed ID: 135968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of immunotherapy in acute myelogenous leukemia.
    Foon KA; Smalley RV; Riggs CW; Gale RP
    Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial.
    Matthay RA; Mahler DA; Beck GJ; Loke J; Baue AE; Carter DC; Mitchell MS
    Cancer Res; 1986 Nov; 46(11):5963-8. PubMed ID: 3530442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationships between clinico-therapeutic parameters and immunological status in patients with lung cancer].
    Roviaro GC; Varoli F; Sartori F; Calabrò F; Bortolotti F; Tremolada F; Fattovich G; Cecchetto A; Paruzzolo P
    Minerva Med; 1980 Jun; 71(25):1757-67. PubMed ID: 6997779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of lung cancer patients treated with BCG and/or a soluble BCG fraction (F70) after surgery, radiotherapy and chemotherapy.
    Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P; Madźarova S; Spassova M
    Neoplasma; 1980; 27(1):83-94. PubMed ID: 7374861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.